Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Phase 2 Basket Study of SEA-CD40 Combination Therapies in Advanced Malignancies

NCT04993677 is registered in ClinicalTrials.gov with Seagen Inc. as lead sponsor.

NCT NCT04993677
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04993677 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Phase 2 Basket Study of SEA-CD40 Combination Therapies in Advanced Malignancies
Lead sponsor
Seagen Inc.
Phase
Phase 2
Overall status
Completed
Start date
October 6, 2021
Completion date
November 25, 2024
Enrollment
77 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, non-small- cell lung, melanoma